Stay updated on Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.

Latest updates to the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check17 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check60 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a phase 2/3 study on dupilumab for atopic dermatitis in young children, while adding new information about the study's interventional model, masking description, and collaborators.SummaryDifference13%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.